Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis

doi:10.12998/wjcc.v8.i15.3230

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5690)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

297

WORD

157

HTML

2372

Figures (1-1)

224

Tables (1-3)

254

Sum=3304

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

608

Download

1778

Sum=2386

Aug 6, 2020 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 6, 2020; 8(15): 3230-3239
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3230

Full Size Figure Download Figure

Figure 1 Survival time for metastatic colorectal adenocarcinoma patients with or without palliative primary tumor resection. A: Total patients with M1a diseases; B: Patients with M1a diseases (liver metastasis); C: Patients with M1a diseases (lung metastasis); D: Patients with M1b diseases.

Citation: Li CL, Tang DR, Ji J, Zang B, Chen C, Zhao JQ. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis. World J Clin Cases 2020; 8(15): 3230-3239
URL: https://www.wjgnet.com/2307-8960/full/v8/i15/3230.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i15.3230